Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Prevention of CMV/EBV Reactivation By Double-Specific T Cells in Patients after Allogeneic Stem Cell Transplantation: Results from the Randomized Phase I/IIa Multivir-01 Study

Blood (2023) 142 (Supplement 1): 6849.

https://doi.org/10.1182/blood-2023-178273

Published: 2023

Journal Articles

Substantial Alteration of Allogeneic Stem Cell Grafts Imposed By COVID-19 Pandemic Related Recommendations

Blood (2022) 140 (Supplement 1): 7563–7564.

https://doi.org/10.1182/blood-2022-167702

Published: 2022

Journal Articles

Influence of Conditioning Regimen Intensity on Outcomes Post-Allogeneic Transplantation for AML in Complete Morphological Remission

Tommy Alfaro, Fotios V. Michelis, Jonas Mattsson, Ivan Pasic, Mats Remberger, Auro Viswabandya, Dennis D.H. Kim, Igor Novitzky-Basso, Rajat Kumar, Jeffrey H. Lipton, Wilson Lam, Arjun D. Law, Armin Gerbitz

Blood (2022) 140 (Supplement 1): 12840–12841.

https://doi.org/10.1182/blood-2022-162279

Published: 2022

Journal Articles

ATG and Post-Transplant Cyclophosphamide Predisposes to Inferior Outcome When Using Cryopreserved Stem Cell Grafts

Igor Novitzky-Basso, Mats Remberger, Carol Chen, Ivan Pasic, Wilson Lam, Arjun Law, Armin Gerbitz, Auro Viswabandya, Jeffrey H. Lipton, Dennis Dong Hwan Kim, Rajat Kumar, Jonas Mattsson, Fotios Michelis

Blood (2021) 138 (Supplement 1): 479.

https://doi.org/10.1182/blood-2021-151744

Published: 2021

Journal Articles

Risk Factors for Primary and Secondary Graft Failure in Allogenic Hematopoietic Cell Transplantation: A Single Center Study

Zeyad Al-Shaibani, MD, Eshrak AL-Shaibani, MD, Mats Remberger, PhD, Wilson Lam, MD, Arjun Law, MD, Fotios V. Michelis, MD PhD, Auro Viswabandya, MD, Dennis Dong Hwan Kim, MD, Jeffrey H. Lipton, MD PhD, Jonas Mattson, MD PhD, Rajat Kumar, MD

Blood (2019) 134 (Supplement_1): 2046.

https://doi.org/10.1182/blood-2019-124208

Published: 2019

Journal Articles

Patient Age and Donor HLA Matching Can Stratify Allogeneic Hematopoietic Cell Transplantation (HCT) Patients into Prognostic Groups: A Collaborative Study

Sunu Cyriac, MD MBBS, Auro Viswabandya, MD, Zeyad Al-Shaibani, MD, Jeffrey H. Lipton, MD PhD, Rajat Kumar, MD, Wilson Lam, MD, Dennis Dong Hwan Kim, MD, Arjun Law, MDDM, Tobias Gedde-Dahl, MD PhD, Yngvar Floisand, MD PhD, Mats Remberger, PhD, Jonas Mattsson, MD, Fotios V. Michelis, MD PhD

Blood (2019) 134 (Supplement_1): 3341.

https://doi.org/10.1182/blood-2019-125941

Published: 2019

Journal Articles

Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Intensity

Hideki Nakasone, Mats Remberger, PhD, Lu Tian, PhD, Petter Brodin, MD PhD, Bita Sahaf, Fang Wu, Robert Lowsky, MD, Jonas Mattsson, MD PhD, Robert S. Negrin, MD, David B. Miklos, Everett Meyer, MD PhD

Blood (2014) 124 (21): 2537.

https://doi.org/10.1182/blood.V124.21.2537.2537

Published: 2014

Journal Articles

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Gabriel Afram, MD, Jose Antonio Pérez Simón, MD, PhD, Mats Remberger, PhD, Teresa Caballero-Velázquez, MD, PhD, Rodrigo Martino, MD, PhD, Jose Luis Piñana, MD, Olle Ringden, MD, Albert Esquirol, MD, Dolores Caballero, MD, PhD, Irene Garcia, MD, Lucía López-Corral, MD, PhD, Jordi Sierra, Oriana López-Godino, Per T. Ljungman, MD, PhD, Jesus F San Miguel, MD, PhD, Hans Hagglund, MD PhD

Blood (2013) 122 (21): 4611.

https://doi.org/10.1182/blood.V122.21.4611.4611

Published: 2013

Journal Articles

Hypogammaglobulinemia In Children Undergoing SCT: An Immunoglobulin Isotype Class Switch Arrest?

Henric Lindqvist, MD, Mats Remberger, PhD, Berit Sundberg, Mehmet Uzunel, PhD, Jacek Winiarski, MD, PhD, Mikael Sundin, MD, PhD

Blood (2013) 122 (21): 5473.

https://doi.org/10.1182/blood.V122.21.5473.5473

Published: 2013

Journal Articles

The Role Of Vitamin D In Pediatric Hematopoietic Stem Cell Transplantation

Magnus EA Hansson, MD, BA, Anna-Carin Norlin, MD, Brigitta Omazic, MD, PhD, Ann-Charlotte Wikström, MD, PhD, Jacek Winiarski, MD, PhD, Mats Remberger, PhD, Mikael Sundin, MD, PhD

Blood (2013) 122 (21): 5483.

https://doi.org/10.1182/blood.V122.21.5483.5483

Published: 2013

Journal Articles

Graft Failure In Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Richard Olsson, MD, PhD, Daniel Moreno Berggren, MD, Olle Ringden, MD, PhD, Jonas Mattsson, MD, PhD, Mats Remberger, PhD

Blood (2013) 122 (21): 4559.

https://doi.org/10.1182/blood.V122.21.4559.4559

Published: 2013

Journal Articles

Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-up of a Randomized Study of the Nordic Bone Marrow Transplantation Group

Tapani Ruutu, MD PhD, Eeva Juvonen, MD PhD, Mats Remberger, MD PhD, Kari Remes, MD PhD, Liisa Volin, Jonas Mattsson, MD PhD, Anne Nihtinen, MD, Hans Hagglund, MD PhD, Olle Ringden, MD PhD

Blood (2011) 118 (21): 488.

https://doi.org/10.1182/blood.V118.21.488.488

Published: 2011

Journal Articles

NK cells expressing inhibitory KIR for non–self-ligands remain tolerant in HLA-matched sibling stem cell transplantation

Andreas T. Björklund, Marie Schaffer, Cyril Fauriat, Olle Ringdén, Mats Remberger, Christina Hammarstedt, A. John Barrett, Per Ljungman, Hans-Gustaf Ljunggren, Karl-Johan Malmberg

Blood (2010) 115 (13): 2686–2694.

https://doi.org/10.1182/blood-2009-07-229740

Published: 2010

Journal Articles

Risks and Benefits of Unrelated Donor Peripheral Blood Progenitor Cells (PBPC) in Children and Adolescents with Acute Leukemia.

Mary Eapen, MBBS, Olle Ringden, MD, PhD, Franco Locatelli, MD, PhD, Haydar Frangoul, MD, Mats Remberger, MD, Mary J. Laughlin, MD, Vanderson Rocha, MD, PhD

Blood (2008) 112 (11): 977.

https://doi.org/10.1182/blood.V112.11.977.977

Published: 2008

Journal Articles

Pre-Transplant Hyperferritinemia Is Associated with Low Incidence of Chronic Gvhd, High Relapse Rate and Impaired Survival in Patients with Hematological Malignancies after Allogeneic HSCT

Hans Gustaf Hagglund, Fryderyk Lorenz, Mats Remberger, Bjorn Wahlin, Anders Wahlin

Blood (2008) 112 (11): 4299.

https://doi.org/10.1182/blood.V112.11.4299.4299

Published: 2008

Journal Articles

Prospecitve Quantitative PCR Monitoring of Allogeneic Stem Cell Transplant (SCT) Patients at High Risk for EBV Associated PTLD.

Hamdy Omar, MD, Hans Hägglund, MD, PhD, Åsa Gustafsson-Jernberg, MD, PhD, Katarina Le Blanc, MD, PhD, Jonas Mattsson, MD, PhD, Mats Remberger, PhD, Olle Ringdén, MD, PhD, Elda Sparrelid, MD, PhD, Mikael Sundin, Jacek H. Winiarski, MD, PhD, Zhibing Yun, PhD, Per T. Ljungman, MD, PhD

Blood (2007) 110 (11): 2969.

https://doi.org/10.1182/blood.V110.11.2969.2969

Published: 2007

Journal Articles

Effect of Busulphan Dose Adjustment on Regimen-Related Toxicity.

Zuzana Hassan, MD, PhD, Mats Remberger, PhD, Olle Ringden, Gunnar Oberg, Albert N. Bekassy, MD, PhD, Moustapha Hassan

Blood (2006) 108 (11): 314.

https://doi.org/10.1182/blood.V108.11.314.314

Published: 2006

Journal Articles

Effects of Photopheresis on Mononuclear Cells from Healthy Individuals.

Gunilla Kumlien, MD, Mats Remberger, PhD, Olle Ringdén

Blood (2005) 106 (11): 1903.

https://doi.org/10.1182/blood.V106.11.1903.1903

Published: 2005

Journal Articles

Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors

Mats Remberger, Dietrich W. Beelen, Axel Fauser, Nadezda Basara, Oliver Basu, Olle Ringdén

Blood (2005) 105 (2): 548–551.

https://doi.org/10.1182/blood-2004-03-1000

Published: 2005

Journal Articles

Increased Risk for EBV-Lymphoma after Allogeneic Hsct in Adult Lymphoma Patients?A Retrospective Study of Reduced Compared to Myeloablative Conditioning.

Hans G. Hagglund, MD, PhD, Mats Brune, MD, PhD, Gunnar Oberg, MD, PhD, Hans Hagberg, MD, PhD, Niklas Theorin, MD, Mats Remberger, PhD, Eva Kimby, MD, PhD.

Blood (2004) 104 (11): 5116.

https://doi.org/10.1182/blood.V104.11.5116.5116

Published: 2004

NARROW

Prevention of CMV/EBV Reactivation By Double-Specific T Cells in Patients after Allogeneic Stem Cell Transplantation: Results from the Randomized Phase I/IIa Multivir-01 Study

Substantial Alteration of Allogeneic Stem Cell Grafts Imposed By COVID-19 Pandemic Related Recommendations

Influence of Conditioning Regimen Intensity on Outcomes Post-Allogeneic Transplantation for AML in Complete Morphological Remission

ATG and Post-Transplant Cyclophosphamide Predisposes to Inferior Outcome When Using Cryopreserved Stem Cell Grafts

Risk Factors for Primary and Secondary Graft Failure in Allogenic Hematopoietic Cell Transplantation: A Single Center Study

Patient Age and Donor HLA Matching Can Stratify Allogeneic Hematopoietic Cell Transplantation (HCT) Patients into Prognostic Groups: A Collaborative Study

Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Intensity

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Hypogammaglobulinemia In Children Undergoing SCT: An Immunoglobulin Isotype Class Switch Arrest?

The Role Of Vitamin D In Pediatric Hematopoietic Stem Cell Transplantation

Graft Failure In Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-up of a Randomized Study of the Nordic Bone Marrow Transplantation Group

NK cells expressing inhibitory KIR for non–self-ligands remain tolerant in HLA-matched sibling stem cell transplantation

Risks and Benefits of Unrelated Donor Peripheral Blood Progenitor Cells (PBPC) in Children and Adolescents with Acute Leukemia.

Pre-Transplant Hyperferritinemia Is Associated with Low Incidence of Chronic Gvhd, High Relapse Rate and Impaired Survival in Patients with Hematological Malignancies after Allogeneic HSCT

Prospecitve Quantitative PCR Monitoring of Allogeneic Stem Cell Transplant (SCT) Patients at High Risk for EBV Associated PTLD.

Effect of Busulphan Dose Adjustment on Regimen-Related Toxicity.

Effects of Photopheresis on Mononuclear Cells from Healthy Individuals.

Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors

Increased Risk for EBV-Lymphoma after Allogeneic Hsct in Adult Lymphoma Patients?A Retrospective Study of Reduced Compared to Myeloablative Conditioning.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only